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ABSTRACT 
 
Porous Membrane-Based Sensor Devices for Biomolecules and Bacteria Detection. 
(August 2012)  
Pei-Hsiang Tsou, B.S., National Chiao Tung University, Taiwan;  
M.S., Texas A&M University 
Chair of Advisory Committee: Dr. Jun Kameoka 
 
 Biological/biochemistry analyses traditionally require bulky instruments and a 
great amount of volume of biological/chemical agents, and many procedures have to be 
performed in certain locations such as medical centers or research institutions. These 
limitations usually include time delay in testing. The delays may be critical for some 
aspects such as disease prevention or patient treatment. One solution to this issue is the 
realization of point-of-care (POC) testings for patients, a domain in public health,  
meaning that health cares are provided near the sites of patients using well-designed and 
portable medical devices. Transportation of samples between local and central 
institutions can therefore be reduced, facilitating early and fast diagnosis.  A closely 
related topic in engineering, lab-on-a-chip (LOC), has been discussed and practiced in 
recent years. LOC emphasizes integrating several functions of laboratory processes in a 
small portable device and performing analysis using only a very small amount of sample 
volume, to achieve low-cost and rapid analysis. From an engineer’s point of view, LOC 
is the strategy to practice the idea of POC testing.  
 iv
This dissertation aimed at exploring the POC potentials of porous membrane-
base LOC devices, which can be used to simplify traditional and standard laboratory 
procedures. In this study, three LOC prototypes are shown and discussed. First the 
protein sensor incorporating with silica nanofiber membrane, which has shown 32 times 
more improvement of sensitivity than a conventional technique and a much shorter 
detection time; secondly the bacteria filter chip that uses a sandwiched aluminum oxide 
membrane to stabilize the bacteria and monitor the efficacy of antibiotics, which has 
reduced the test time from 1 day of the traditional methods to 1 hour; the third is the 
sensor combining microfluidics and silica nanofiber membrane to realize Surface 
Enhanced Raman Spectroscopy on bio-molecules, which has enhancement factor 109 
and detection limit down to nanomolar, but simple manufacturing procedures and 
reduced fabrication cost. These results show the porous-base membrane LOC devices 
may have potentials in improving and replacing traditional detection methods and 
eventually be used in POC applications.  
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NOMENCLATURE 
 
AAO Anodic Aluminum Oxide  
CFU Colony-Forming Unit  
ELISA Enzyme-Linked Immunosorbant Assay 
LED Light-Emitting-Diode 
MIC Minimum Inhibitory Concentration 
MPIPC Methoxyphenylisoxazolylpenicillin  
MSSA Methicillin-Sensitive Staphylococcus Aureus 
MRSA Methicillin-Resistant Staphylococcus Aureus 
PBS Phosphate-Buffered Saline  
PDMS Polydimethylsiloxane 
POC Point-of-Care 
PVP Polyvinylpyrrolidone 
SEM Scanning Electron Microscope 
SERS Surface Enhanced Raman Scattering 
SOG Spin-on-Glass Coating Solution 
VAP Ventilator-Associated Pneumonia 
VCM Vancomycin 
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1. INTRODUCTION: POINT-OF-CARE-TESTING AND LAB-ON-A-CHIP 
 
1.1 Point-of-Care-Testing 
 Healthy living has become an important subject as human’s basic urges such as 
hunger and thirst are gradually satisfied, whether in a convenient city or in a rural 
countryside. Patients go to clinics or hospitals and look for clinicians’ diagnosis when 
some symptoms have interrupted their daily lives. A typical diagnostic process may 
involve assessing information from body fluids such as blood, urines, saliva, etc. 
Clinicians then determine proper treatments for patients based on biological and 
chemical parameters in these body fluids. A central laboratory is often required to 
analyze these specimens for the next few hours or days. For example, a blood testing 
conducted in laboratory based system requires 11 steps, which are: (1) order the test; (2) 
process the test request; (3) draw blood sample; (4) transport the sample; (5) label and 
store the sample; (6) centrifuge the sample; (7) sort the serum sample to analyzers; (8) 
analyze the sample; (9) review the results; (10) report the results to the department; (11) 
clinicians determine the treatment.1 For some aspects such as disease prevention or 
patient treatment, the delays may be critical. To resolve this issue, some clinicians have 
adapting point-of-care (POC) testing, in which small and portable analytical devices are 
used near patients’ sites to monitor their health conditions. The operator of the POC 
testing device can be patients themselves, or proper trained persons, depending on 
situations of patients’ health status.  
____________ 
This dissertation follows the style of Lab on a Chip. 
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The abovementioned blood testing example, if conducted with a POC system, may take 
only 5 steps: (1) order the test; (2) draw blood sample; (3) analyze the sample; (4) 
review the result; (5) clinicians determine the treatment.1 The steps that the sample has 
to be transported to the central lab, analyzed, and reported back to the department are 
simplified by using the POC system to perform rapid but reliable analysis of the sample. 
Currently POC testing devices have been performed in several situations: bedside 
glucose testing, urine pregnancy testing, infectious disease testing, fecal occult blood 
testing, dipstick urinalysis, probing the information of blood gases and electrolytes, 
coagulation, cardiac markers, Hemoglobin A1c, and intraoperative parathyroid hormone, 
and physician-performed microscopy.2 Optimal POC test device might require 
characteristics such as: results are strong correlated to those from standard laboratory 
procedures, minimum variability in test results, easy interpretation and rapid availability 
of test results, rapid availability of test results, portability of testing equipment, low 
maintenance, minimal or no use of blood, minimal cost, fool-proof testing methodology, 
stability of test equipment in various different environments, long shelf lives of reagents, 
and well quality control. POC test device also have to be developed and tested under the 
government’s regulations, which usually require manufacturers to provide solid 
scientific evidences to show both safety and efficacy of the devices.1,3 
 
1.2 Lab-on-a-Chip  
 Some of the requirements of POC testing devices are interestingly coincide with 
the features of lab-on-a-chip (LOC) concepts from an engineer’s point of view. LOC 
 3
devices emphasize biological, physical, and/or chemical testing on a small portable 
device that has one or a few laboratory functions, and focus on handling relative smaller 
volumes of analytes, fluid down to picoliter scale, than conventional laboratory 
procedures to achieve low cost and rapid analysis. The LOC device is categorized as a 
subset of microelectromechanical systems (MEMS), which utilizes the matured 
semiconductor device fabrication technologies, such as thin film deposition, 
photolithography, and etching to create small electro/mechanical devices with 
component size ranging from 1 to 100 µm. The development of LOC devices can be 
dated back to Stephen C. Terry’s gas chromatograph article published in 1979.4 In the 
paper, he described a system including a sample injection valve, a capillary column, and 
a thermal conductivity detector that were fabricated on a same silicon substrate. The use 
of photolithography and chemical etching techniques reduced the size 3 orders of 
magnitude compared to traditional bulky instruments. The progresses of fabricating 
channels, pumps, mixers, valves, and fluidic control structures on substrate during the 
following decades have further improved the development of LOC devices. The first 
commercialized LOC product was claimed by Agilent Technologies for the company’s 
2100 Bioanalyzer in 1999.5  This LOC system consisted a glass-based microfluidic chip 
with 16 sample wells and inter-connected channel networks, and a computer system with 
signal reader and analyzer to perform electrophoretic or flow cytometric assay. The 
substrates used for LOC devices can be silicon, glass, or polymers, such as elastomer 
polydimethylsiloxane (PDMS), thermoplastic polymethylmethacrylate (PMMA), 
polycarbonate (PC), cyclic olefin copolymer (COC), polysulfone (PSU), polypropylene 
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(PP), polyethylene (PE), polyoxymethylene (POM), liquid crystal polymer (LCP), and 
polyether ether ketone (PEEK). Photolithography is still widely used for fabricating 
silicon and glass-based LOC devices. For polymeric materials, the fabrication methods 
of polymeric LOC devices can be molding, hot/cold embossing, injection molding, 
thermoforming, laser ablation, and micromilling. The fabrication methods of LOC 
devices are briefly described as follows: 
 (1) Photolithography:  Typically fabricated on silicon and/or silica based 
substrates, the procedures involve using photoresist, photomask, and UV to define the 
2D pattern on the substrates, followed by physical or chemical etching process to create 
3D structures.  
 (2) Laser ablation: Laser ablation creates fine features by concentrating laser 
energy on a small spot with a few µm in diameter to evaporate or sublimate unwanted 
part of target material.6-9  
 (3) Micromilling: Similar to traditional milling, micromilling can create small 
structures in µm scale on metals and polymers using cutter with dimension as small as 
10 µm in diameter.10-12  
 (4) Replica molding: The liquid bulk polymer/curing agent mixture is poured on 
a mold and solidified after polymerization and cross-linking.13-16   
 (5) Injection molding: The polymer granulate is heated to melt and injected into 
the cavity of a mold. Specific structure is then formed after the molten polymer cools 
and hardens.17-20  
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 (6) Hot embossing: The polymer foil is placed on mold and heated to melt. A 
substrate plate with rough surface vertically presses the melt into the mold. After the 
molten polymer cools to demolding temperature, it is separated from the mold by raising 
the substrate plate. Hot embossing is featured by the residue layer of polymer that is 
adhered on the rough surface of the substrate place. It helps to remove the structured 
polymer from the mold during the demolding process.21-23   
 (7) Thermoforming: Thermoforming heats a polymer sheet to the temperature so 
that the solid sheet can be pressed into the mold and plied to a specific 3D structure. The 
minimum size of feature depends on the pattern of the mold.24-27  
 Polymer LOC devices are featured by significant lower material cost than silicon 
and glass. However, different strategies have to be adapted to drive sample fluid into the 
devices made of different material. The propulsive force of sample fluid can be 
classified into 5 major categories of methods: capillary-, pressure-, centrifugal-, 
electrokinetic-, and acoustic-driven flows:28  
 (1) Capillary: Liquid is moved by the capillary forces. The material of LOC 
substrate may be hydrophilic such as glass or nitro-cellulose, and the movement can be 
controlled by the wettability and the feature size of porous structure of substrate.29-32   
 (2) Pressure: Pressure driven flow is the most commonly used method in LOC 
devices. External pressure source such as syringes, micropumps, vacuum pumps, or 
devices that can create pressure gradients are used to drive the liquid movement in a 
channel or porous material. Pumping rate and pressure difference between inlet and 
outlet directly affect the flow speed of the liquid. In some applications when additional 
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control-channel layers are used, the liquid movement is controlled by the frequency of 
squeeze and release of the control channels. Pressure driven LOC devices have achieved 
a certain degree of large scale integration by adapting elastomer as LOC substrate and 
the peristaltic actuation of the control-channel layers.33-36  
 (3) Centrifugal: Liquid is moved by the centrifugal force, which acts on the 
liquid along radial outward direction in a channel on a rotating disk. Liquid movement is 
affected by parameters such as central fugal force, Euler force, Coriolis force, and 
capillary force.37-41  
 (4) Electrokinetic: Definitions of electrokinetic phenomena cover several effects 
such as electroosmosis, electrophoresis, and dielectrophoresis. But when the bulk liquid 
movement in a LOC device is emphasized, the “electrokinetic” usually means 
electroosmosis. The motion of liquid in the channel is induced by the interaction 
between the surface charges of the channel wall and the electric field applied at the both 
ends of the channel. The feature of electrokinetic driven LOC devices is simplicity 
compared to others. The anode and cathode side of the applied electric field, and the 
polarity of surface charges decide the direction of the flow.  Electrowetting driven flow 
is also defined in this category. The sample and reagent move in the form of individual 
droplets. The movement of droplet is steered by the electrode array embedded under an 
insulated and hydrophobic layer. It is featured by programmable movement with a 
control electronic instrument.42-45  
 (5) Acoustic: The droplet on a hydrophobic surface in air is moved by the surface 
acoustic waves induced by a piezoelectric transducer.46-49  
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 Each of these transportation methods may not be applied to all materials, and the 
material properties of reagents and substrates may affect the movement of the liquids. 
For example, capillary driven flow of water-based sample may be applied to glass-based 
LOC devices, but not for hydrophobic polymer-based LOC devices. On the other hand, 
electrowetting may transport water droplet much better on hydrophobic surface than 
hydrophilic glass surface of LOC devices. In summary, the advantages of LOC devices 
are often describe as: low consumption of sample and reagent fluids, short analysis time, 
fast heat generation and dissipation, high surface to volume, ratios, integration of several 
functions, high throughput, low fabrication cost per device in mass production, and etc. 
studies because of integration of functionality, smaller fluid volumes and stored energies. 
These advantages, as abovementioned, may aide the development of POC in the future. 
It is worth noted that in most cases the instruments of measurement are not considered in 
the integration of the LOC devices, partially because of the limitation of current 
technologies. Table 1 shows a simplified comparison of the suitability of several 
expected LOC features for various transport methods of sample/reagent fluids.28  
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Table 1. Suitability of LOC features for different transport methods. 
 
 
 9
2. ELECTROSPUN MEMBRANE FILTER DEVICE FOR BIOMOLECULAR 
DETECTION 
 
2.1 Introduction 
 The background knowledge of two subjects is introduced: electrospinning and 
ELISA. The electrospinning is the technique used for fabricating the detection medium, 
a porous membrane that is composed of long nanofibers, similar to a nonwoven fabric. 
Therefore the terms "membrane" and "fiber mat" are used interchangeably in the texts. 
ELISA is the acronym of Enzyme-linked immunosorbent assay, which is a matured 
biochemistry assay able to quantify the amount of molecule in a sample solution. It is the 
reference method to be compared with by this new membrane-base assay. 
 
2.1.1 Electrospinning 
 Electrospinning is a way to produce polymer fibers with diameters from several 
micrometer to tens of nanometer. Its history can date back to Anton Formhals’ patent in 
1934. The core of this technique is to charge polymer solution with high voltage until 
ejection. The polymer solution jets then solidify because of solvent evaporation or cooler 
environment in the air. The choices of polymer are diverse, such as polyethylene oxide 
(PEO), nylon, polyvinyl alcohol (PVA), polyurethane (PU), liquid crystal like 
polyphenylene, polyaniline, and natural material such as silk from silkworms or spiders, 
DNA, etc.50-64 Metal or semiconductor oxide fibers can also be electrospun by adding 
oxide precursors to the polymer solutions and removing the polymer parts by calcination. 
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65-67 The features of the fibers made from electrospinning are their continuity and small 
diameter. The nonwoven fiber mats are therefore highly porous with extremely high 
surface-to-volume ratio. In some application such as biomedical scaffolds, catalysts, or 
sensors, this high surface-to-volume ratio can improve efficiency of recovery or reduce 
reaction time.  
 The components for elctrospinning generally include the polymer solution with a 
syringe/needle, a mechanical pump, a high voltage power supply, and an electrical 
grounded fiber collector. The characteristic of polymer solution may affect the final form 
of fiber. For example, if the solution has lower viscosity, the jets tend to form short and 
thin fibers, or even from droplets instead of fibers. Basic controllable parameters in 
electrospinning include electric field (kV/cm) between the nozzle and the collector, flow 
rate (μL/min), the supply rate of the solution, deposition distance (cm), the distance 
between the needle tip and the collector, concentration of polymer or other ingredients, 
and type of collector.  
 Electrospinning has been found useful in several fields such as modifying 
mechanical, electrical, optical properties, sensor, filtration, biomedicine, etc. For 
example, electrospun nylon fibers were incorporated into bulk epoxy resin to increase 
the stiffness and mechanical strength of the material; electrospun polyaniline/PEO fibers 
less than 100 nm were found diameter-dependent conductivities; uniaxially aligned 
polyvinylpyrrolidone (PVP) electrospun fibers can alter light polarization; heat 
depolymerizable polycarbonate nanofibers were used as sacrificial templates to produce 
nanofluidic channels; electrospun polyaniline/poly-(ethylene oxide) (PANI/PEO) 
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nanowire sensors can detect ammonia gas at very low concentration; electrospun 
membranes have been used as filters to separate aerosol, electrospun poly(e-caprolactone) 
(PCL) fiber membranes were used as biomedical scaffolds to improve tissue growth; 
electrospun poly(vinyl alcohol) fiber membranes can supports enzymes and control the 
release rate.68-72 
 
2.1.2 Enzyme-Linked Immunosorbent Assay (ELISA) 
 The detection of antigen or antibody amount is crucial in medical science. For 
example, antibodies in human bodies are released by B-cells when B-cells sense antigens 
such as bacteria or virus. Although various kinds of antibodies are produced, each kind 
of antibody only recognizes specific receptors on the surface of antigens. The 
recognition may rely on correct fitting of shape and size of antibody/antigen. Immune 
defense is triggered once a certain kind of antibodies is binding to the receptors, and T-
cells then come to destroy the antigen. Therefore, the presence of certain antibodies 
implies the existence of the antigens of some known diseases in blood.  
 Enzyme-Linked Immunosorbant Assay (ELISA) is a common assay used in 
biochemistry for quantifying target antigen or antibody amount, basing on the fact that 
an antigen and its corresponding antibody can form a protein complex when they interact. 
ELISA is typically practiced in a 96-well or 384-well polystyrene plate. For example, a 
typical procedures of “sandwich ELISA” can be described as:  
(1) Antigen/antibody coating: a solution of antigen (to detect antibody) or antibody 
(to detect antigen) for catching target protein is dispensed in to a well of ELISA plate. 
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The antigens or antibodies in solution can be adsorbed on the surface by Van der Waals 
force as they diffuse to the surface.  
(2) Blocking agent coating: a solution of non-reacting protein, or blocking agent, is 
added into the well after removing the antigen or antibody solution. The purpose is to 
block unoccupied sites, where no antigen or antibody is attached, to prevent unwanted 
nonspecific binding of other molecules in later steps.  
(3) Sample adding and incubation: A sample with target protein (antibody or 
antigen) is added after removing the blocking agent. The plate is left for 15 minutes of 
incubation to make antigen and antibody fully react.  
(4) Wash: The well is washed 3 to 6 times by buffer solution to remove excess 
proteins that have not been bound.  
(5) Enzyme-linked antibody adding: The secondary antibodies that are linked with 
detection enzymes horseradish peroxidase (HRP) and able to recognize target protein are 
applied into the well after wash. The plate is left for 15 minutes of incubation to make 
target protein and enzyme-linked antibody fully react. The HRP is an enzyme for 
catalyzing the color change of substrate (a detection reagent) in later step. 
(6) Wash: The well is washed 3 to 6 times by buffer solution to remove excess 
proteins that have not been bound. 
(7) HRP-substrate adding: The HRP-substrate is added into the well after wash. The 
plate is left for 15 minutes before measurement. The HRP enzyme on the secondary 
antibody, acting as an amplifier, can keep catalyzing the substrate to change the color of 
HRP-substrate. The degree of color change caused by the concentration of color product 
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can be measured using an ELISA reader to assess the optical density value of the sample. 
The amount of target protein can therefore be estimated by comparing the measured 
value with a standard curve, typically from a serial dilution of target protein solution 
with known concentration.  
 Many types of ELISA-like protocols have been created and they can be practiced 
on various kinds of surfaces, not limited to the ELISA plate. The detection relies on 
adsorption of the pre-coated antigens or antibodies on the surface for catching the target 
protein, and the diffusion of antigen and antibody. To improve catching ability, one can 
either raise the protein concentration or increase coating/incubation time. However, 
because the size of protein is extremely small compared to the volume of single well, 
most proteins are washed away before diffusing to the proximity of the well surface and 
being adsorbed. The condition worsens in lower concentration since very few proteins 
can attach to the surface. In other word, ELISA’s detection ability is limited by the solid 
surface. A clinical report pointed out ELISA’s poor efficiency of the hybridization 
resulted in low sensitivity and selectivity.73 
 The features of electrospun fiber mat may improve ELISA’s detection limit. 
Similar assay can be practiced in the fiber mat’s filter-like structure. This kind of 
modification may provide at least two advantages. First, the fiber mat has extremely 
large surface area that can adsorb much more “catcher” protein and provide more 
exposure area to the sample. Second, the sample is essentially forced to pass the porous 
structure, and fewer proteins will be wasted. The above idea is practiced in the 
experimental part. In this subtopic, electrospun PVP/silica fibers mats were studied, 
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including fabrication conditions versus resultant fibers, and the improved biochemistry 
sensing ability in ELISA using calcined silica fiber mats. The water soluble PVP was 
chosen because no toxic solvent was required for the fabrication. 
 
2.2 Experimental 
 The fabrication processes of electrospun PVP/silica fiber mat are introduced here. 
A detection assembly with electrospun silica fiber mat is explained as well as its 
performances.  
 
2.2.1 Fabrication of Electrospun Fiber Mat  
 The chemicals used for electrospinning were mainly PVP (MW=1 300 000, 
Aldrich), Spin-on-Glass Coating (SOG) Solution (IC1-200, Futurrex, Inc.), and butanol 
(Solvent Diluent SD4, Futurrex, Inc.). The SOG was essentially a silica source, as it has 
been known that proteins tend to be adsorbed on silica surface.  
 The 80% SOG solution was prepared by diluting original SOG with butanol. The 
polymer solution for electrospinning was prepared by adding 0.32 g of PVP into 8 ml of 
the 80% SOG solution so that the PVP concentration was 0.04 g/ml. These parameters 
were chosen because they provided relative stable conditions for fabricating thinnest 
electrospun fibers. The mixture was magnetically stirred for 12 hours and then loaded 
into the syringe with 24 gauge stainless steel needle. The distance between grounded 
collector and needle was kept 5 cm; the pump rate was set to 8 μL/min; the voltage of 
power supply was set to 7 kV. A 2 cm-by-2 cm iron mesh was loosely attached on the 
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collector for receiving the fiber and for facilitating transportation. After 5 minutes of 
electrospinning, the fiber mat was transferred to a furnace (Isotemp Muffle Furnace 550, 
Fisher Scientific) and calcined at 500 °C for 12 hours. After the calcination, the PVP 
was removed and the composition of electrospun fiber mat was solely silica. The fiber 
mats were fabricated using the above parameters because they resulted in stable and 
uniform fiber mat with consistent dimension. 
 
2.2.2 ELISA Using Electrospun Fiber Mat 
 The chemicals used for these modified ELISA tests were bovine serum albumin 
(BSA) as blocking agent, monoclonal mouse anti-FLAG M2 antibody (Sigma) and 
monoclonal mouse anti-c-Myc antibody (Sigma) as primary antibodies, goat anti-mouse 
HRP (Jackson ImmunoResearch Laboratories) and donkey anti-goat HRP (Jackson 
ImmunoResearch Laboratories) as secondary antibodies. The electrospun fiber mats 
were fabricated by procedures described in the previous section.  
 The concept of using electrospun silica fiber mats to improve conventional 
ELISA detection was tested by following methodology. First, a primary antibody was 
coated on the fiber mat, followed by blocking agent coating. The primary antibody acted 
as an active site for capturing target protein. Second, a secondary antibody conjugated 
with enzyme was applied to the fiber mat, which simulated the application of target 
molecule. If the primary and secondary antibody matched each other, they formed a 
stable bonding and remained on the fiber mat after wash. Thirdly, a substrate was then 
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applied and emitted light signals that was catalyzed by the enzyme on the secondary 
antibody. The strength of signals also reflected the concentration of target molecule.  
 
2.2.2.1 Non-Specific Binding of Protein on Electrospun Silica Fiber Mat  
 Although it is known that proteins can be well adsorbed on glass surface, it is 
uncertain if they can be adsorbed on the surface of electrospun silica fiber mats. 
Therefore, a non-specific protein binding test was conducted on those fiber mats. A 
functional protein (primary antibody) and a non-functional protein (BSA) were applied 
to the fiber mats respectively as the first layer. The results should directly reflect the 
choice of this first layer if the binding is “non-specific”. Detail procedures are described 
as follows (Figure 1): 
 (1) Two fiber mats were placed on a glass slide. One of the fiber mats was coated 
with 10 μl of BSA (1 μg/μl) as the negative control (protein A). The other fiber mat was 
coated with 10 μl of primary antibody (protein B) monoclonal mouse anti-FLAG M2 (1 
μg/μl) and incubated overnight.  
 (2) Blocking agents were applied to both fiber mat and incubated at room 
temperature for 30 minutes, followed by 5 minutes of wash with Tween 20/phosphate-
buffered saline (PBS) for 5 minutes.  
 (3) The target protein, simulated using Goat anti-mouse HRP (protein C), was 
applied to both fiber mats and incubated at room temperature for 30 minutes.  
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Figure 1. Procedure for the protein-attachment test for electrospun silica nanofiber 
membranes. Proteins A, B, and C denote BSA, monoclonal mouse anti-FLAG M2 
antibody, and goat anti-mouse HRP. 
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 (4) Both fiber mats were washed using Tween 20/PBS 4 times, 10 minutes each 
time, at room temperature.  
 (5) Substrates were then applied to both membranes. The results were recorded 
on x-ray films for 10 seconds and 2 minutes.  
 
2.2.2.2 Specific-Binding of Primary and Secondary Antibody  
 The experiment in the previous section was to confirm that the proteins (primary 
antibody and BSA) could non-specifically attach to the surface of electrospun silica fiber 
mat, which lead to a new ELISA device integrating the fiber mat to investigate the 
efficiency of protein detection. (Figure 2) This device was connected to a vacuum source 
to drive the solution through the multi-layer structure. The functions of each layer were 
described as follow: 
 (1) stainless steel mesh: to reduce the impact on contact and protect the fiber mat.  
 (2) electrospun silica fiber mat: to adsorb the proteins for ELISA; 1.3 cm-by-1.3 
cm in dimension. 
 (3) filter paper: to guide the liquid, reduce the impact of vacuumm and the 
deformation that might break the fiber mat. 
 (4) plastic plate: to guide the liquid and concentrate the flow in the central 3 mm 
diameter hole. 
 (5) rubber ring: to avoid leakage during the vacuum. 
 (6) sink/drain: to drain the liquid.   
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Figure 2. Layered structure of the nanofiber membrane device. Arrows indicate the 
direction of flow of the solution. 
 
 
The device was evaluated based on the abovementioned methodology. Briefly speaking, 
the device should show differences between the sample with target molecules and the 
negative control. The target molecule was simulated by the matched secondary antibody 
(goat anti-mouse HRP) that can conjugate with the primary antibody. Typical procedures 
using this ELISA device involve dispensing reagents on the fiber mats and meanwhile 
removing them using an adjustable valve to control the drain speed, which are described 
as follows:  
 (1) Primary antibody coating: 3 ml of primary antibody (monoclonal mouse anti-
c-Myc antibody, 5 μg/ml); slow drain.  
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 (2) Wash: 2 ml of wash buffer solution (Tween 20/PBS); fast drain.  
 (3) Blocking: 3 ml of blocking agents (BSA, 4% in PBS); slowly drain.  
 (4) Wash: 2 ml of wash buffer solution; fast drain. 
 (5) Secondary antibody coating: 2 ml of secondary antibody (goat anti-mouse 
HRP or donkey anti-goat HRP, 3.1 and 12.5 ng/ml each); slow drain.   
 (6) Wash: 3 ml of wash buffer solution; fast drain.  
 The time was less than 3 minutes for fast drain and 10-15 minutes for slow drain. 
The purpose of slow drain was to increase the chance of protein adsorption or specific 
binding. The fiber mat was then removed from the device and immersed in substrates 
(Glo Substrate Reagent Pack, R&D Systems) for 5 seconds. The catalyzed substrates and 
those from traditional ELISA were measured together using an ELISA plate and 
compared. 
 
2.2.3 Minimum Detection Limit 
 The minimum detection limit of the fiber mat was investigated following similar 
procedures as described in the Specific-binding experiments. Diluted enzyme-linked 
secondary antibody, ranging from 0 to 1.5 ng/ml, was used to catalyze the substrate. The 
more sensitive luminometer (TD 20/20, Turner Designs) instead of the ELISA reader 
was used to measure fluorescence strength. 
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2.3 Results and Discussion 
2.3.1 Scanning Electron Microscope Characterization of Electrospun Silica Nanofibers 
 SEM images of silica nanofibers fabricated with different process parameters 
(Figure 3) show that the diameter of electrospun silica nanofibers was influenced by 
both the concentration of PVP and the volume ratio of SOG. It is found that the average 
fiber diameters generally decreased as solute concentration (the PVP concentration or 
SOG volume ratio in the solution) decreased or as the applied voltage increased (Figures 
4). The polymer solution with SOG less than 80% of the volume ratio was found to 
result in fibers with diameters of less than 150 nm without much influence of applied 
voltage. The standard deviation of fiber diameter obtained at each voltage was found 
increased when the average diameter was larger. Thicker fibers were occasionally 
observed in the form of two merged fibers.  
These SEM images were also used for estimating the porosity and the surface-to-
volume ratio of the electrospun fiber mat. (Figure 5) The porosity, shown as pore ratio, 
was defined by dividing the area that was free from fibers by the total area of the SEM 
image. Porosity was found to decrease when deposition time increased, which was 
reasonable since the gradually accumulated fibers on the collector would result in 
thicker fiber mat and smaller pores in average. The surface-to-volume ratio was 
calculated by dividing the surface area of a fiber by its volume. For example, the 
electrospun fibers with 50 to 400 nm in diameter have the ratios ranging from 8 x 107 to 
107. The porosity and the surface-to-volume ratio of the fiber mats that were used in the 
experiments were 0.0685 and 4 x 107.  
 22
 
 
Figure 3. Scanning electron micrographs showing the diameters of electrospun silica 
nanofibers fabricated with various concentrations of PVP and volume ratios of SOG. (A) 
PVP, 0.02 g/ml; SOG, 100%, the inset shows a electrospun nanofiber with 57 nm in 
diameter. (B) PVP, 0.06 g/ml; SOG, 100%. (C) PVP, 0.04 g/ml; SOG, 40%. (D) PVP, 
0.04 g/ml; SOG, 80%. The following parameters were kept constant for all experiments: 
feeding rate of 8 μl/min, deposition distance of 5 cm, applied voltage of 7 kV, needle 
size of 24 gauge, and calcination temperature of 773 K for more than 12 hours. 
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Figure 4. (A) The diameter of calcined silica nanofibers as a function of applied 
voltages for different PVP concentrations. (B) Nanofiber diameter as a function of 
applied voltages for different SOG concentrations.  
 
 
Figure 5. (A) Pore ratio as a function of deposition time. (B) Surfaceto-volume ratio as a 
function of the diameter of nanofibers and the ELISA plate. The square indicates the 
surface-to-volume ratio of the nanofiber membrane used for protein detection. The 
surface-to-volume ratio of the ELISA plate is defined as the inner surface area of a 
single well divided by its volume. 
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2.3.2 Nonspecific Binding of Protein on Electrospun Silica Fiber Mat 
 The x-ray films recorded the fluorescence (shown as dark areas on the films) 
from the slides for 10 seconds of short exposure and 2 minutes of long exposure, 
following the addition of substrate. (Figure 6) Long exposure time helped to locate weak 
fluorescence signals that were not detected in short time. The gray-scale images, 
converted from the scanned x-ray films, were used to estimate the differences. By 
defining pure white as 0% and pure black as 100%, the emission efficiency of each 
condition was calculated from its average gray-scale value within the square area. Under 
this definition, the emission of site A (negative control) and site B (primary antibody) 
were 11.3% and 20.8% for short exposure, and 14.1% and 56.5% for long exposure. A 
similar experiment was conducted on a plain glass slide, which showed much weaker 
adsrption. (Figure 7) These results confirmed that: (1) the high surface-to-volume ratio 
of electrospum silica fiber mat resulted in better protein-attachment ability than that of 
the plain glass slide, and (2) the procedures associated with specific binding of antibody 
and antigen in the ELISA technique can also be applied to the electrospun nanofiber 
membrane.  
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Figure 6. X-ray photos after 10 seconds short exposure and 2 minutes long exposure for 
the protein-attachment test on electrospun silica nanofiber membranes. Site A: results 
using BSA as negative control. Site B: results using primary antibody.  
 
 
Figure 7. X-ray photos after 10 seconds short exposure and 2 minutes long exposure for 
the protein-attachment test on a plain glass slide. Site A: results using BSA as negative 
control. Site B: results using primary antibody. 
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2.3.3 Specific-Binding of Primary and Secondary Antibody   
 Results of the specific-binding experiments using the matched secondary 
antibody (anti-mouse) and the negative control (anti-goat) on platforms of the traditional 
one (ELISA) and the electrospun silica fiber mat (nanofiber) are shown in Figure 8. For 
each concentration of secondary antibody, we can easily discover that (1) the signal 
strength from the matched one using electrospun silica fiber mat was the highest, and (2) 
the differences of signal strength between the matched one and the negative control 
using electrospun silica fiber mat were more distinct than which using traditional ELISA. 
These results also suggested that the detection limit could be further lower using the 
electrospun silica fiber mat.  
 
2.3.4 Minimum Detection Limit 
 The methodology we looked for the minimum detection limt was by finding 
minimum concentration of target molecules (secondary antibody) emitting signal 
strength barely distinguishable from the zero concentration (sample without any target 
molecules). Since the signal strength measured directly from the luminometer had the 
unit of relative light intensity (RLU), which was a relative value, the measured RLU 
values were all normalized by setting the value at zero concentration as 1. Average and 
standard deviation were calculated from 6 measurements of every concentration of target 
molecule. The results of previous section implied the limit might locate at concentration 
lower than 3.1 ng/ml, therefore we started our investigation from 1.5 ng/ml. The results 
show the minimum detection limit using the electrospun fiber mat was about 0.19 ng/ml 
 27
or 1.6 pM, and a good linearity in low concentration range. (Figure 9) When compared 
with the results from traditional ELISA, which had minimum detection limit at 6.25 
ng/ml, electrospun silica fiber mat improved the detection limit for about 32 times. 
(Figure 10) These outcomes suggested that higher surface-to-volume ratio indeed 
improved the detection limit, and the target molecule of picomolar concentration may be 
estimated by performing linear interpolation on a known curve. 
 
 
 
Figure 8. Signal strength (relative light unit, RLU) of specific and nonspecific-binding 
experiments performed using conventional ELISA and electrospun silica nanofiber 
membranes. From left to right for each experimental condition: specific binding on the 
ELISA plate, specific binding on the membranes, nonspecific binding on the ELISA 
plate, and nonspecific binding on the membranes. These results indicate that electrospun 
silica nanofiber membranes have much better sensitivity than does conventional ELISA. 
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Figure 9. Normalized signal strength as a function of secondary antibody concentrations 
on electrospun silica nanofiber membranes. The inset graph illustrates the linear 
relationship at low concentrations. The average fiber diameter of the membranes is 100 
nm with standard deviation 30 nm. 
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Figure 10. Detection results of electrospun nanofiber membrane biosensor and 
traditional ELISA. 
 
 
 In additional to the concern of detection limit, this membrane-based method has 
the advantages of short experimental time and reduced material costs. Traditional ELISA 
requires a long overnight incubation, because the diffusion-driven molecules have to 
travel much longer distance to attach the surface and to interact with other molecules. 
Each well of the plate has to be filled with a certain amount of reagents in each step, but 
only molecules near the well surface can participate in the reaction. On the other hand, 
the approach using electrospun silica fiber mat force most molecules in the volume of 
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reagents to travel trough the porous structure of the membrane by the external vacuum 
source. The molecules can therefore have much higher probability to contact the surface. 
The time for non-specific binding of protein or specific antibody-antigen interaction can 
be less than 15 minutes in each step. This improvement only requires 40 μl of solution 
for fabricating the 1.3 cm-by-1.3 cm electrospun fiber mat and the followed calcination. 
 
2.4 Summary 
 A new electrospun silica membrane-base sensor device for biomolecules was 
studied. The dimension of the electrospun nanofiber was controlled by process 
parameters of electrospinning, such as electric field strength and polymer concentration. 
This biosensor drove the reagents by external vacuum source, forcing molecules to travel 
through the porous membrane. The much higher surface-to-volume ratio of the 
electrospun silica fiber mat resulted in better detection limit of target molecules than 
traditional ELISA. The linearity in low concentration range can be applied to detect 
target molecules down to picomolar concentrations. Compared to the 1 day of traditional 
assay, this new detection method only takes as short as 1 hour for all procedures of an 
experiment. The much shorter experimental time makes this electrospun silica 
membrane-base sensor device an ideal candidate for biomolecule and POC applications. 
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3. ANODIC ALUMINUM OXIDE MEMBRANE FILTER DEVICE FOR BACTERIA 
VIABILITY DETECTION 
 
3.1 Introduction 
 The purpose of the project is to reduce the time in antibiotic efficacy tests by 
using anodic aluminum oxide membrane (AAO) membranes. The background 
knowledge of traditional methods monitoring bacteria viability against antibiotics, and 
the AAO membrane is introduced.  
 
3.1.1 Bacteria Viability against Antibiotics 
 The growth of bacteria reflects whether the environment they stay is favorable or 
not. Bacteria continue to multiply until that the supportive resources are depleted or the 
multiplcation is interrupted by external factors. By observing the growth of bacteria 
against antibiotics, a clinician can select a proper antibiotic to treat bacterial diseases 
with less chances inducing antibiotic resistance. For example, patients receiving 
intubation in Intensive Care Units often catch ventilator-associated pneumonia (VAP) 
when the intubation is longer than 2 days. It is because pathogens, such as 
Staphylococcus aureus, Pseudomonas aeruginosa, and Enterobacter species, can directly 
infect the lung through the endotracheal tubes, resulting in 24 – 50% of mortality rate. 
Some studies showed that this high mortality for VAP patients may be attributed to 
inadequate antimicrobial treatment and increasing antibiotic resistance of pathogens, and 
may be resolved by rapid determination of initial antimicrobial drugs.74-77 Currently, 
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several methods that can evaluate antibiotic efficacy are available, such as disc diffusion, 
Etest, broth dilution, or agar dilution methods. In these methods, the effect of antibiotic 
is quantified by minimum inhibitory concentration (MIC), which is the minimum 
antibiotic concentration that can prevent the growth of bacteria.78-85 Researchers who 
want to know the MICs may observe the differences of bacterial growth under the effect 
of antibiotics after overnight incubation, whether in the form of bacterial colonies on an 
agar plate or the turbidity of a solution. For example, in disc diffusion or Etest methods, 
the bacteria suspension is first inoculated evenly on the surface of the agar plate with 
antibiotic discs or Etest strips placed on it. The MIC is measured by the diameter of 
bacteria-free zone on the next day. In agar or broth dilution methods, the bacteria 
suspension is inoculated on a series of agar plates incorporated with different 
concentration of antibiotic, or inoculated into tubes with broth solution and various 
concentration of antibiotic. The MIC is the minimum concentration that has no colony 
on the agar plate or has transparent solution after overnight incubation. The detection 
time for these tests to determine the efficacy of antibiotics is usually more than 24 hours. 
This delay may result in increase risk of hospital mortality, during which the antibiotic-
resistant bacteria may worsen the infection.86  
 This 1-2 days duration is required because bacteria have to keep multiplying until 
visible differences form among the several antibiotic concentrations. The comparison 
requires the information such as the numbers of colonies in agar dilution method, the 
optical density number in broth dilution method, and the diameter of the bacteria-free 
zone in disc diffusion and Etest methods. Essentially, the methods presenting bacterial 
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viability affect the length of the experimental time. Therefore, the delay can be reduced 
if rapid monitoring of cell viability and better detection limit are achievable.  
 
3.1.2 Anodic Aluminum Oxide (AAO) Nanoporous Membrane 
 In the membrane separation field, polymeric membranes are commonly used 
because of their low cost and wide availability on the market.87 The choices of polymeric 
membranes are abundant, such as cellulose acetate, nitrocellulose, cellulose esters, 
polysulfone, polyether sulfone, polyacrilonitrile, polyamide, polyimide, polyethylene, 
polypropylene, polytetrafluoroethylene, polyvinylidene fluoride, polyvinylchloride.88 
The inorganic option made of aluminum oxide, AAO nanoporous membrane, actually 
had once been commercialized for years by Whatman Ltd.89 Compared with any 
polymeric porous membrane, AAO membrane has features such as more uniform pore 
size, higher porous density, more parallel pore alignment, more rigid and flatter. These 
advantages of AAO membrane are the results of its complete different fabrication 
processes. The dimension of pore can be controlled precisely by using optimal 
fabrication parameters such as electrolyte, applied voltage, temperature, etc. in anodic 
oxidation process.90 Most applications of AAO membranes have concentrated in the 
fabrication of nanostructures.91-103  
 So far, the applications of AAO membranes directly in biological field are 
limited and their potentials in antibiotic screening have not been fully explored.104-106 As 
previously described, rapid monitoring of cell viability and better detection limit can 
result in faster evaluation of antibiotic efficacy. These criterions could be satisfied by 
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adapting a functional fluorescent stain SYTO 9 and the membrane filtration method. 
SYTO 9 green-fluorescent molecules can label cells by binding to their nucleic acids. 
The membrane filtration method can concentrate distributed cells at any moment of 
bacterial multiplication, and the features of the commercial AAO membrane making it 
ideal for such application. For that reason, a rapid antibiotic screening device consisted 
of an AAO nanoporous membrane and an incubation reservoir was made and applied to 
antibiotic efficacy test. Conceptually, bacteria in the sample and the antibiotic to be 
tested were reacted in the reservoir. Affected by the antibiotic, the bacterial 
multiplication was interrupted, resulted in ruptured cell walls. The bacteria were then 
filtered and stained on the AAO membrane. Ruptured bacteria were broken in pieces and 
drained during the filtration; live bacteria remained on the AAO membrane. The 
effectiveness of the antibiotic for the bacteria was determined by comparing the numbers 
of cells on the fluorescence image of the membrane over time. 
 
3.2 Experimental 
3.2.1 Detection Device and Equipment 
 A filter-device incorporating 0.22 μm pore size aluminum oxide membrane 
(Anodisc 13, Whatman) was used to trap E. coli and S. aureus which have the size of 1-2 
μm. AAO membrane is inorganic and does not react with any reagent in the experiments. 
The alignment of pore has only one direction and the variation of pore size is very small. 
These features provide better quality control of the experimental results over most 
polymeric membranes, in which the pores are created by radiation or fabrics, and the 
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alignment and size of pore can have broader distribution. This AAO membrane was 
sandwiched sequentially by rubber O-rings to avoid leakage, and plastic plates to fix the 
shape. A reservoir was attached to one side of the plate mainly for incubation. The size 
of the reservoir was about 12.5 mm in inner diameter and 10 mm in height. The 
dimension of the filter-device was designed as same as that of a common glass slide (7.5 
cm by 2.5 cm) so that it could be placed on the stages of most microscopes. (Figure 11) 
 The equipments aiding the detection consisted of a vacuum unit and a 
microscopy unit. The vacuum unit was used to hold the device and drain the solution in 
the reservoir of the device by a vacuum pump. The microscopy unit contained a blue 
(473 nm) light-emitting-diode (LED) for excitation, an optical filter set (35002v2, 
Chroma) for separating the emitted green fluorescence from the blue light, a movable 
stage, and a digital camera (DP20, Olympus) for recording the fluorescence images. 
(Figure 12)  
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Figure 11. Photograph and schematic diagram of the assembled AAO membrane filter 
device for bacterial sensing. The scale bar is 2.5 cm.  
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Figure 12. Photograph of the detection system. Top panel: the detection system includes 
a vacuum unit and a microscopy unit. Bottom panel: schematic diagram of the 
microscopy unit.  
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 The green fluorescence stain used for staining the bacteria was prepared by 
dissolving SYTO 9 powder (Invitrogen) in 5 ml purified water. Typical fixation/staining 
of bacteria included following steps: a 100 μl sample solution was dispensed into the 
reservoir of a filter-device and drained. The cells on the membrane were then stained and 
washed. Staining procedures were performed after fixing the bacteria. The 50 μl stain 
solution was dispensed into the reservoir and drained immediately after 10 min of 
staining process. Excess stains were removed prior to the observation by flashing with 
500 μl phosphate-buffered saline (PBS, AS ONE Corporation). 
 
3.2.2 Calculation of Cell Number 
 The exact detection area was 0.76 mm by 1 mm for 10x objective lens. The size 
of each recorded image was 1200 pixel by 1600 pixel. The quality of each grayscale 
image was improved by ImageJ software to reduce background noise of the images. The 
cell number of bacteria on the membrane was determined based on following three steps. 
(1) A rectangular (600 pixel by 800 pixel) region of interest (ROI) that has the most 
bacterial cells was selected manually. The bright spots inside the ROI were viewed as 
cells, except the spots that were obviously too large. (2) Various single-cell regions on 
the same image were manually selected. These single-cell areas were compared to define 
a proper threshold value of grey-scale histogram and the average pixel size of single 
bacteria cell. (3) By applying the same threshold, total cell count in the ROI were 
calculated by dividing the signal area of ROI by the single-cell area. The quotient was 
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then times the ratio of the reservoir area over the ROI area. The product was viewed as 
the total cell count of the injected solution.  
 
3.2.3 Calibration Curve of AAO Membrane in Bacteria Sensing 
 The methodology described in the previous section is actually an estimation of 
exact number of bacteria. The distribution of bacteria cells on the membrane and the 
selected ROI area may cause variations of the results. Therefore a calibration curve 
showing the relationship between the exact number of bacteria and the cell count using 
the membrane can provide a good reference of reliability.  
 E. coli K-12 bacteria in buffer solution (101 to 107 /ml) were used for calibrating 
the membrane. The staining procedures were the same as previously described. For 
comparison, the actual cell concentration of the same bacterial solution was also 
evaluated by counting colony-forming unit (CFU) on agar plates as in colony culturing 
method.  
 
3.2.4 Monitoring Bacterial Growth with Antibiotic  
 To prove the concept that this membrane-base device could be used for antibiotic 
efficacy test, bacteria E. coli were incubated with antibiotic Pansporin and buffer 
solution PBS (negative control) respectively in the reservoir of the device, and observed 
at different time points. The mixture of 800 μl of liquid culture medium, 100 μl of 
Pansporin (1 mg/ml) or PBS for negative control, and 100 μl of E. coli solution (about 
104 CFU/ml) was dispensed into the reservoir of the filter-device, followed by agitation 
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and incubation at 37C using a shaking incubator (PIC-100S, AS ONE Corporation). 
Because the fluorescent stain might affect the bacterial multiplication, the devices at 
different time points were prepared separately. Three devices were prepared for 0, 30, 
and 60 minutes of incubations. After the incubation, the solution in the reservoir was 
drained using the vacuum unit. The staining, washing, and cell counting processes were 
the same as formerly described.  
 The influence of temperature was also studied by following the same procedures 
abovementioned but in room temperature instead of 37C.  
 
3.2.5 Determination of MIC 
 The susceptibility of bacteria to antimicrobial agents was determined by agar 
dilution method in accordance with the Clinical and Laboratory Standards Institute 
(CLSI) Guidelines. To determine the MIC, several concentrations of the antibiotic 
Pansporin (1 mg/ml to 10 ng/ml) and 100 μl E. coli solution (about 104 CFU/ml) were 
prepared for individual devices. These devices were incubated at 37C in the shaking 
incubator and the number of survived E. coli was counted. The conventional agar 
dilution method, taking 24 hours for whole procedures, was used to confirm the results. 
In this test, the diluted antibiotic Pansporin solution was added into molten agar for the 
preparation of antibiotic-incorporated agar plates with various concentrations of the 
antibiotic. E. coli solution was then inoculated on each plate (1.5×104 CFU/plate). The 
MIC was determined after 24 hours of incubation. 
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3.2.6 Antibiotic Efficacy Testing for Patients’ Samples   
 The device was used in the screening process of the antibiotics MPIPC and VCM 
on the MSSA and MRSA from patients’ respiratory secretions provided by Saga 
Medical School Hospital, Japan. The sample type is sputum. The 800 μl liquid culture 
medium, 100 μl antibiotic solution (4 μg/ml for MPIPC and 20 μg/ml for VCM), and 
100 μl sample solution (about 104 CFU/ml) were dispensed in series into the reservoir of 
a device without draining. The rest of procedures were as same as described in previous 
section for rapid antibiotic efficacy screening, except that the results were obtained right 
after 0, 60, 120, and 180 minutes. 
 
3.3 Results and Discussion 
3.3.1 Calibration Curve of AAO Membrane in Bacteria Sensing 
 The scatter plot of bacterial concentrations obtained by the conventional bacterial 
culture method as a function of the one obtained by the filter-device sensor system is 
shown (Figure 13). The R-square value of log-log fit was obtained as high as 0.9426, 
meaning that the AAO nanoporous membrane can determine the bacteria concentrations 
as precisely as the conventional bacterial culture method. Polycarbonate (PC) 
membranes, which are commonly used in bacteria sensing applications, were also tested 
under same conditions (not shown). However, the fluorescence outside the stained cells, 
caused by the absorption of the fluorescent stain on the surface of PC membranes, 
became considerably high noise. The pliability of PC membranes also impeded the 
focusing on the surface. In addition, the alignment of the pores in PC membranes is 
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randomly distributed, due to the track-etching process to generate pores. On the other 
hand, we found the rigidity, flatness, low background fluorescence, uniform pore size 
and parallel pore alignment in AAO nanoporous membrane made the AAO membrane a 
better candidate in this application.   
 
 
 
Figure 13. Scatter plot of cell counts from agar plate and filter-device. The high R2 value 
suggests the device is reliable for bacterial enumeration at the range of 102 to 105/ml. 
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3.3.2 Monitoring Bacterial Growth with Antibiotic 
 Typical fluorescence images of the surface of membrane from the results of 
incubated solutions with and without Pansporin are shown in Figure 14. The number of 
bacteria in the sample solution with Pansporin was obviously less than that in the 
negative control sample immediately after 30 and 60 minutes. The SYTO 9 stained 
bacteria by binding to their nucleic acid. The green fluoresced objects were defined as 
live bacteria in our assay, since bacteria with damaged cell walls and membranes were 
easily ruptured and flushed away via pores when solutions were passed through the 
AAO membrane. 
 Number of bacterial cells remaining on the membrane was counted for each 
experiment. We defined the index of antibiotic efficacy (Index) to represent the changes 
of both sample and control with time:   
 
 Index = Log10{(Nx)/(N0)} - Log10{(Cx)/(C0)} 
 
 Where Nx and  N0 are the numbers of live cells from sample with the antibiotic at 
x and 0 minute, and Cx and C0 are the numbers of live cells from negative control at x 
and 0 minute. 
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Figure 14. Color-inverted fluorescence images of E. coli (3.9 x 104 CFU/ml) on AAO 
membranes at different time of incubation process. Immediately after 0, 30, 60 minutes, 
the image of negative controls (A-C) and samples with antibiotic Pansporin 1 mg/ml (D-
F). The number of bacteria with antibiotics obviously decreased, since the antibiotics 
had interrupted the bacterial growth. The scale bar is 50 μm. 
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 In general, the number of bacteria increased with time in the negative controls 
(Cx/C0>1), but decreased with time in the sample with the antibiotic (Nx/N0<1). If an 
antibiotic has better efficacy for the tested bacteria, the index will have a more negative 
and steeper slope in our custom-defined index. The index was also applied to both cases 
with and without incubation.  
 Without incubation process, the enumeration showed live cell count was unstable 
in Pansporin after 60 minutes, either 45% increase or 33% decrease. On the other hand, 
the result with incubation showed homogeneous reduction (>98%) in live cell count after 
60 minutes. Figure 15 shows a comparison of the antibiotic efficacies with and without 
incubation processes. It was obvious that the incubation is a required step to determine 
the antibiotic efficacy. This difference can be attributed to that most antibiotics, 
including Pansporin, are designed to disrupt the synthesis of bacterial cell wall during 
cell fission process. Since the optimal cell division of E. coli was at 37 C, these results 
fitted our expectation and the index reasonably reflected the antibiotic efficacy on the 
bacteria.  
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Figure 15. Index of antibiotic efficacy of E. coli as a function of time. The solid line has 
a steeper slope than the dotted line, meaning that the antibiotic requires incubation to 
take effect. 
 
 
3.3.3 Determination of MIC 
 Figure 16 shows the fluorescence images of E. coli exposed to various 
concentrations of Pansporin with 0, 30, and 60 minutes of incubations. The reduction of 
the number of bacteria was obvious along observation time in the 1 mg/ml and even the 
diluted 1 μg/ml of the antibiotic concentration. However, there was no significant 
difference between the sample with 10 ng/ml Pansporin and the negative control. 
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Figure 16. Color-inverted fluorescence images of E. coli on AAO membranes at 
different time and specific concentrations of the antibiotic with incubation process. 
Immediately after 0, 30, 60 minutes, the images of samples with antibiotic Pansporin 1 
mg/ml (A-C), 1 μg/ml (D-F), and 10 ng/ml (G-I). The scale bar is 50 μm in width. 
 
 
 The graph of antibiotic efficacy index as a function of time indicates diluted 
antibiotics have fewer efficacies (Figure 17A). The slope was negatively proportional to 
the concentration during the 60-minute period for 1 μg/ml to 1 mg/ml. The slope was 
nearly horizontal for the 100 ng/ml sample for more than 1 hour, and the difference 
between 100 ng/ml and 1 μg/ml samples was noticeable. Accordingly, we estimated that 
the MIC of Pansporin was between 100 ng/ml and 1 μg/ml. This estimation was 
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confirmed by the conventional agar dilution method (Figure 17B). Our approach appears 
exceeding, as it took only 1 hour to determine the antibiotic efficacy compared to the 
typical 24 hours required for conventional techniques. 
 
 
 
Figure 17. (A) Index of antibiotic efficacy as a function of time and Pansporin 
concentration. The antibiotic effect on the bacteria can be divided into 3 groups: 
ineffective for 10 and 100 ng/ml; effective for 1, 10, and 100 μg/ml; the most effective 
for 1 mg/ml. (B) Growth of bacteria using conventional agar dilution method. MIC is 
between 1 μg/ml and 100 ng/ml, which is the same as our estimation based on the filter-
device system. 
 
 
3.3.4 Antibiotic Efficacy Testing for Patients’ Samples 
 This technique was furthermore applied to the screening of antibiotics for MSSA 
and MRSA samples from the patients in Saga Medical School Hospital. The 
fluorescence images of the results are shown in Figure 18, after their background noises 
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were subtracted using ImageJ. The cell growth of MSSA was reduced by the antibiotic 
MPIPC. For MRSA sample, the growth of MRSA was undeterred by MPIPC but 
interrupted by VCM. The index of antibiotic efficacy as a function of time is shown in 
Figure 19. In this graphs, the slopes of MSSA-MPIPC and MRSA-VCM samples were 
more negative with time than those of MRSA-MPIPC. The effectiveness of the two 
antibiotics was easily distinguishable in 1 hour. 
 
3.4 Summary 
 We have developed a rapid antibiotic efficacy screening system by using a filter-
device incorporating aluminum oxide nanoporous membrane. The MIC obtained by the 
filter-device system matched well with the one obtained by the conventional approach. 
Compared to the conventional antibiotic efficacy test using agar plate, the filter-device 
system can dramatically reduce the test time from 24 hours to 1 hour, aiding fast 
decision making of antibiotics in medical treatments. This test-in-vitro setup can help 
tailor antibiotic therapy, and reduce microbial antibiotic resistance by shortening 
antibiotic exposure on human body. Meanwhile, very small amount of sample is 
required for the test, and the procedures are feasible. Its simple design facilitates mass 
production of the filter-device as well. These characteristics make the filter-device 
system a potentially valuable tool in POC applications in the near future. 
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Figure 18. Color-inverted fluorescence images of MSSA and MRSA on AAO 
membranes at different time with incubation and antibiotics. Immediately after 0, 60, 
120, 180 minutes, the images of MSSA samples with MPIPC 4 μg/ml (A-D), MRSA 
samples with MPIPC 4 μg/ml (E-H), and MRSA samples with VCM 20 μg/ml (I-L). The 
growth of MRSA was not affected by MPIPC, but impeded by VCM. The scale bar is 50 
μm.  
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Figure 19. Index of antibiotic efficacy as a function of time and concentration of 
antibiotic MPIPC and VCM. The growths of MSSA and MRSA are reduced by MPIPC 
and VCM respectively. 
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4. MICROFLUIDIC/ELECTROSPUN MEMBRANE OPTOFLUIDIC DEVICE FOR 
SURFACE ENHANCED RAMAN SPECTROSCOPY  
 
4.1 Introduction: Surface Enhanced Raman Spectroscopy 
 Raman spectroscopy is a spectroscopy used to study Raman scattering, and 
named after the Indian physicist C. V. Raman, who was devoted to the research of light 
scattering that led to the discovery of the scattering in 1928. Raman scattering is one of 
the several cases of the interaction between an electromagnetic (EM) wave and a matter, 
if we describe light as EM wave. When an incident monochromatic EM wave travels 
trough a material, it may induce oscillation of the electron clouds of the molecules or 
atoms. The oscillation of electrons becomes a source of EM wave and radiates with a 
new wavelength and direction. This phenomenon is the scattering of EM wave. Most of 
the induced EM waves have the same wavelength as the incident EM wave, which is 
defined as elastic scattering. A small fraction of the induced EM waves may have 
different wavelength from the incident one, which is defined as inelastic scattering. 
Raman scattering is one of the inelastic scattering cases, and the shift of the wavelength 
is caused by the interaction of the incident EM wave and the material, originated from 
the change of vibration and rotation energy states of molecules. The fraction of the 
inelastic scattering of EM wave is typically very small (1:107) and the intensity of 
Raman scattering is much weaker than the elastic scattering ones, so Raman scattering is 
not as noticeable as elastic scattering in most cases. The detection of Raman scattering 
usually requires a strong incident monochromatic source to induce, a good dichroic filter 
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to separate the scattered light from the incident one, and a sensitive receiver to sense the 
signals. The degrees of shifting between incident and scattered wavelength depend on 
the scattering material, and are usually expressed as Raman shift (λincident-1- λemitted-1) in 
the unit of (cm-1). Raman spectrum of a molecule, shown as intensity versus Raman shift, 
is viewed as its fingerprint since it provides information down to molecular structures.  
 SERS is a surface-enhanced detection of Raman scattering, in which the Raman 
signals of the molecules are greatly enhanced by the rough metal surfaces absorbing the 
molecules. This improvement was accidentally found by Martin Fleischman and his 
coworkers in 1974 from pyridine adsorbed on electrochemically roughened silver.107 
Several different kinds of structures have also been explored, such as gratings,108-109 
island films,110-112 colloids,113-116 nanoparticle array,117-122 nanorod arrays,123-126 metal-
coated nanoparticles,127-128 and nanoshells.129-135 The excitation of localized surface 
plasmon resonances on those structures contributes the amplification of light and result 
in the enhancement.136 The “hotspots” describe the regions on the SERS substrate where 
the electromagnetic enhancements are the highest, and result in strong SERS signals of 
molecules. The signal enhancement, represented as enhancement factor, can be as large 
as 1014 at those hotspots.137 However, locating the hotspots sites is prerequisite before 
acquiring SERS signals, and the adsorption of molecules on the surface of nanoparticles 
mostly rely on diffusion, which is random and has low reproducibility of experiments. 
Fabricating nanostructures using cleanroom instruments and techniques may improve the 
uncertainty of the hotspot position. Periodic metal nanostructures for a SERS substrate 
can be determined by photolithography prior to experiments. For example, the e-beam 
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lithography can fabricate metal nanoparticle array with designated shape and size,117-121 
or create template of wells for nanoparticle cluster arrays.122 On the other hand, 
fabrication of these SERS substrates requires more complicate processes, which are 
often expensive. Long analysis time remains unsolved since analyte molecules still have 
to diffuse to the hotspots.  
 To address the aforementioned limitations, a novel optofluidic device integrating 
an electrospun silica nanofiber membrane and microfluidic channels was developed, 
which could provide significant sensitivity of SERS signal while drastically reduce 
fabrication cost. This optofluidic device has a unique junction with an electrospun silica 
nanofiber membrane sandwiched between the inlet and outlet channels, where gold 
nanoparticles adsorbing analyte can be trapped. The porous structures of the junction are 
smaller than the 60 nm gold particles, and the gold particles are aggregated at the 
junction along with target molecules when vacuum force is applied. 
 
4.2 Experimental 
4.2.1 Fabrication of Silica Nanofiber Integrated Optofluidic Device 
 The silica nanofiber integrated optofluidic device was fabricated by two 
independent processes: electrospinning and soft-lithography of polydimethylsiloxane 
(PDMS). Electrospinning was for depositing silica nanofibers on the glass slide, the 
bottom layer of the device; soft-lithography of PDMS was for preparing the microfluidic 
channels, the top layer of the device.  
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 The polymer solution for electrospinning was prepared by mixing 6.4 ml of SOG 
solution (IC1-200, Futurrex, Inc.), 1.6 ml butanol (Solvent Diluent SD4, Futurrex, Inc.) 
and 0.32 g PVP (MW=1 300 000, Aldrich). The resultant mixture was an 8 ml of 80% 
SOG and 0.04 g/ml PVP solution. The polymeric composite solution was electrospun 
using 8 cm of deposition distance, 5 kV of voltage (Series 230, Bertan), 4 μL/min of 
pump rate (Pump 11 Plus, Harvard Apparatus), and a 24 gauge of stainless steel needle 
(Hamilton Company). The deposition area was confined by a custom-made plastic mask 
with a 3 mm-by-3 mm opening. The electric field between the needle and the large metal 
collector behind the glass slide allowed the deposition of nanofibers, which stayed firmly 
attached to the glass slide surface after the separation of the plastic mask and the glass 
slide. The deposited composite nanofibers were then calcined at 500 °C for 12 hours to 
remove the PVP and create pure silica nanofibers. Figure 20 illustrates fabrication of 
electrospun nanofiber membrane, and the scanning electron microscope (SEM) image 
shows the resultant electrospun membrane on the glass slide.  
 
 56
 
Figure 20. Fabrication process of the bottom layer of the silica nanofiber membrane 
integrated microfluidic device. The silica nanofiber membrane was deposited on a glass 
slide by electrospinning polymeric composite nanofibers, followed by the removal of the 
polymer at high temperature.  
 
 
 The PDMS microfluidic layer was fabricated by the conventional soft-
lithography molding methods.138-139 The mask for photolithography was designed using 
AutoCAD (Autodesk) and printed by CAD/Art Services Inc. The mold was made by 
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spin-coating (WS-650S, Laurell) photoresist SU-8 2025 (MicroChem Corp.) at 3000 
rpm yielding a 20 μm thickness using 100 seconds of UV exposure (Q4000MA, Quintel) 
followed by developing and a hard bake. The PMDS layer was made by mixing base and 
curing agent (Sylgard 184, Dow Corning) at a 1 to 10 ratio, followed by a molding 
process at 70°C for 2 hours. The chip was assembled using oxygen reactive-ion-etching 
treatment (CS-1701, March Plasma Systems) to bond the PDMS layer and the glass slide 
together as shown in Figure 21. 
 
 
 
Figure 21. Fabrication and assembly process of the silica nanofiber membrane integrated 
microfluidic device. The PDMS microfluidic channels were fabricated via an SU-8 mold 
and bonded with the silica nanofiber membrane bottom layer. 
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4.2.2 Design of Channel Pattern 
 This optofluidic device was designed based on several known phenomena: (1) 
the flow of liquid favors the lowest resistive path; (2) surface variations of an 
electrospun silica nanofiber membrane on glass create nanopores; (3) these nanopores 
allow liquid to flow but block larger particles such as the 60 nm gold and analyte of 
interest. The distance of the junction between the front and rear section of the 
microfluidic channels was 25 m, the shortest path for liquid to flow. (Figure 22) For 
such reason, the solution is expected to travel through this 25 µm channel junction, as 
shown by the red arrows in Figure 22, mechanically trapping the particles at the 
nanofiber membrane and encouraging the gold nanoparticles to accumulate at the 
channel boundary.  
 
4.2.3 Trapping and Aggregation Test 
 In this study, the flow was driven by pressure difference between the inlet and 
outlet channels. Although both applying positive pressure at the inlet or negative 
pressure at the outlet should work, the latter one was adapted. The main consideration 
was to avoid the expansion of the volume inside the PDMS channel that might decrease 
the trapping ability if positive pressure was applied. Therefore, the outlet was connected 
to a 30 ml syringe, serving as a negative pressure source, to drive the liquid into the 
channel and pass through the 25 µm junction. The initial value of the negative pressure 
was estimated to be 1/60 atm (1.7 kPa) after considering the volume of tubing when the 
syringe was fully extracted. 
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Figure 22. Schematic of the assembled device. Top view: the front and rear section of 
the microfluidic channels are bridged by the deposited silica nanofiber membrane; the 
lower panel is the enlarged view of the ends of the two channels. Side view: Red arrows 
indicate the flow direction. The nanopores created by the deposited nanofiber membrane 
enabled the flow through the 25 m bridged region.  
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 Particle trapping efficiency was evaluated by dispensing 20 l of polystyrene (PS) 
beads, prepared from 1000 times diluted 1 m PS microparticles (Sigma-Aldrich), into 
one of the inlet channels, followed by syringe-vacuuming with 1/3 of full extraction. The 
full extraction was not applied, because low pressure drop and the slower flow rate 
facilitated the observation of the aggregation process. Once the aggregation process had 
been shown with the PS microparticles, a similar experiment was conducted using 20 l 
of 60 nm gold nanoparticles (Unconjugated PolyGold, Polysciences, Inc.) and syringe-
vacuuming system with full extraction. Images were taken during the process of 
aggregation using a CCD camera (QuickCam Pro 4000, Logitech).  
 
4.2.4 SERS Signal of Adenine 
 A solution of adenine, a known Raman active analyte, was used to investigate the 
performance of the silica nanofiber integrated optofluidic device as a SERS substrate. 
The maximum solubility of adenine in water was known as 0.976 mg/ml or 7.2 mM.140 
Four adenine dilutions of 100 M, 10 M, and 1 M, and 0.1 M in water were 
prepared from this saturated solution. Each concentration of adenine was then mixed 
with the 60 nm gold nanoparticles with a volume ratio of 1:10 (adenine:gold =1:10). 
SERS signals of the adenine solution were measured after dispensing 10 l of 
adenine/gold solution into the device and vacuuming until the volume at the inlet 
channel appeared nearly empty. The signal was collected at the aggregation spots at the 
boundary of channel and nanofiber membrane. For the non-SERS Raman signal, due to 
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the insolubility of adenine in water at high concentrations, 1 M of adenine was dissolved 
in 1 M HCl, and this was used as the baseline to calculate the enhancement factor. 
 The Raman spectra for the concentration studies was measured using a Horiba 
Jobin-Yvon LabRam IR system, with 785 nm/8 mW laser source, 50 m pinhole, 5 sec 
integration time, 10x/0.25 NA objective lens, and 300 lines/mm grating. The 100 nM 
concentration was detected with a 200 µm pinhole. The Raman spectra used for the 
enhancement factor calculations were collected using a Thermo Scientific DXR Raman 
confocal microscope, with a 780 nm/24 mW diode laser, 50 µm slit, 2.5 sec integration 
time with 60 exposures, 50x/0.5 NA/1.6 µm spot size long working distance objective, 
and 830 lines/mm grating. The spectra were collected using the Omnic Dispersive 
software, which subtracts the background of each signal after collection. 
 
4.3 Results and Discussion 
4.3.1 Trapping and Aggregation Test 
 The trapping efficiency of 1 µm PS microparticles by the silica nanofiber 
membrane integrated microfluidic device was investigated. The average diameter of the 
silica nanofibers used in this experiment was 100 nm, and the thickness of the silica 
nanofiber membrane was estimated in the same order of magnitude from the SEM image. 
Bright field microscope images of the trapping of PS microparticles are shown as a 
function of time in Figure 23. After PS particle solution was dispensed and vacuumed, 
PS particles were visibly trapped and aggregated within 1 minute at the junction of the 
silica nanofiber membrane and the inlet microfluidic channel. More PS microparticles 
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were trapped and accumulated along the channel as time progressed. During the total 
100 minute observation, no additional aggregation was found outside the channel 
boundary, which suggested the nanopores at the junction had successfully block the 
larger PS microparticles.   
 The aggregation pattern of gold nanoparticles (Figure 24) followed the result of 
PS microparticles. The gold nanoparticles were found to accumulate at the end of 
channel in less than 30 seconds. Some of gold nanoparticles at the end of channels were 
aggregated outside of microfluidic channels, it is possibly because the pressure drop 
between two channels was initially high and some nanoparticles were migrated into 
silica nanofiber membranes, and then stopped by dense nanofibers at the vicinity of 
channel ends. Most aggregation of the gold nanoparticles aggregation still occured at the 
channel end, the junction of the membrane and the channel.  
 
4.3.2 SERS Signal of Adenine 
 The SERS signals of different concentrations of adenine are shown in Figure 25. 
The areas of aggregation for the four concentrations were at the end of the inlet 
microchannel with a less than 10 µm sensing area. The signal intensity shows 
concentration dependence at 735 cm-1. However, further investigation is necessary to 
improve the ability to obtain quantitative information and determine the ultimate limits 
of detection. This silica nanofiber integrated microfluidic device could be used to sense a 
signal down to 100 nM without optimization of Raman instrumentation parameters.  
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Figure 23. Bright field microscope images of the trapping of PS microparticles at the 
junction of the inlet microchannel and nanofiber coated channel (yellow arrow). These 
images show that nanopores created at the junction encourage aggregation of the 
microparticles. The scale bar is 20 m. 
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Figure 24. Bright field images of gold nanoparticle aggregation at the junction of the 
inlet microchannel and nanofiber coated channel (yellow arrow). Most of the 
aggregation was concentrated at the 25 m bridged region since the fluidic resistance is 
the lowest. The scale bar is 20 m.  
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Figure 25. The SERS signals of different concentrations of adenine at aggregation spots. 
The 100 nM SERS signal of adenine was acquired using a 200 µm pinhole. Spectra are 
offset for clarity. 
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The time-dependent signal variation of 100 µM of adenine solution was studied 
after dispensing 10 l of adenine/gold solution (9% v/v) into the reservoir of the device. 
SERS spectra were acquired at the end of the inlet microfluidic channel where 
aggregations occurred. The SERS spectra as a function of time are shown in Figure 26. 
No SERS signal of adenine was found at 735 cm-1 at the beginning of the experiment, 
since the surface of PDMS microfluidic channel was hydrophobic and did not allow 
capillary flows. After 8 minutes of vacuuming, the SERS signal of adenine gradually 
formed and intensified over time, saturating after 130 minutes. This result indicates that 
nanoparticles and adenine molecules were continuously trapped at the junction between 
the inlet microfluidic channel and nanofiber membrane, and reach a stability level. 
Although it took 8 minutes before initial detection and 130 minutes before stabilization, 
this flow rate can be significantly enhanced in future versions of the device by surface-
modifying the hydrophobic PDMS channel to be hydrophilic and transporting the liquid 
using electroosmotic flow.42-43,141-142 
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Figure 26. SERS signals of 100 M of adenine obtained by the device at the junction 
between the inlet microfluidic channel and the silica nanofiber membrane as a function 
of time. Spectra are offset for clarity. 
 
 
4.3.3 SERS Enhancement Factor  
 Figure 27 shows the enhancement of Raman intensity at the aggregation spot of 
the device compared to the intensity of 1M adenine without using gold colloid. SERS 
enhancement factor was calculated by comparing the SERS and Raman signal of 
adenine at the 735 cm-1 mode. The analytical enhancement factor (AEF) gives a good 
estimate of the average enhancement factor of the substrate. The normal Raman spectra 
was obtained under the same conditions as the SERS spectra and an AEF of up to 109 
was determined using the following equation:136    
 
 AEF = (ISERS / concSERS) / (IRS / concRS)  
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Where ISERS is the intensity of the enhanced Raman signal at the concentration 
(concSERS), which is 1 µl of 1 µM adenine added to the 10 µl stock gold colloid and 
dispensed into the nanofiber membrane integrated microfluidic device. IRS is the 
intensity of the non-SERS Raman measurement at the measured concentration (concRS), 
which is 300 µl of 1 M adenine without using gold colloid. This enhancement factor 
could be improved by the design of microfluidic channel, the optimization of the 
diameter and density of the electrospun nanofiber, and optimization of Raman 
instrumentation parameters.  
 
 
 
Figure 27. The SERS signal of 1µM adenine at the aggregation spot and the Raman 
signal of 1M adenine without using gold colloid. Spectra are offset for clarity. 
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4.4 Summary 
 We have developed a new optofluidic device that was integrated with a silica 
nanofiber membrane. This device has nanometer scale entrances at the boundary 
between a silica nanofiber membrane and the inlet microfluidic channel, where gold 
nanoparticles and analyte were aggregated. The device was tested with adenine and 
could be used to detect SERS signal down to nanomolar concentrations with a SERS 
enhancement factor of 109 without optimization. This device enables the localization of 
SERS hotspots. Target molecules can be guided to the desired spots instead of being 
absorbed randomly. The substrate can be fabricated consistently with a simple, low cost, 
and widely available methodology: soft-lithography and electrospinning. Once 
optimized, these characteristics may show potential for this approach to be used as a 
robust SERS and POC device. 
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5. SUMMARY 
 
 In this dissertation, three porous membrane-base devices for biological detection 
are demonstrated. These devices share the same features of low cost, high sensitivity, 
rapidity, portability, and the ability to improve traditional detection methods, fulfilling 
some of the requirements for POC test devices. The electrospun silica nanofiber 
membranes played important roles in the filter devices for both ELISA and SERS 
detection. In the case of the immunosorbent assay device, the high surface-to-volume 
ratio feature of electrospun silica nanofiber membrane was exploited to increase the 
detection area and decrease the waste of reagents, showing better detection limit down to 
picomolar range and good linearity of fluorescence intensity and concentration of target 
protein. The hybridization time was reduced from 1 day of conventional ELISA to less 
than 1 hour with improved sensitivity. In the case of the SERS detection device, the 
small surface roughness of the depositied electrospun silica nanofibers membrane on a 
glass slide was utilized to create nanopores after the glass slide was bonded with a 
PDMS microchannel layer. The SERS hotspots were confined near the junction between 
the inlet channel and the membrane instead of randomly distributed. The significant 
enhancement factor 109 and the nanomolar detection limit show potential of this 
detection device once fully optimized. The AAO membrane is the key element of the 
filter device for the bacteria viability detection. The features of uniform pore size, dense 
pore distribution, vertical pore alignment, stiffness, and nonreactive surface of this 
inorganic membrane are advantages over several commonly-used polymeric membranes. 
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The bacteria were therefore observed in a more stable situation, without the concerns of 
autofluorescence, deformation, fouling, and other unwanted incidents that lead to 
miscalculation of the cell count. The antibiotic efficacy was measured in the filter-device 
incorporating AAO membrane. MIC was able to be determined from 1-2 days of 
traditional methods to 1 hour using this AAO membrane device, showing the potential in 
clinical uses to reduce occurrence of microbial antibiotic resistance.  
 Since these membrane-based devices were only prototypes developed in 
academia without optimization, their future forms may be quite different from the 
current ones. For example, the electrospun membrane filter device for biomolecular 
detection can complement low concentration range, which makes it ideal to determine 
minute amount of target molecule after a traditional ELISA is performed but unable to 
sense any signal. The next version of the device may appear in the form of a membrane-
based microcentrifuge tube that is highly compatible with lab equipments. For the 
microfluidic/electrospun membrane optofluidic device for SERS that also utilizes 
electrospun membrane, the device may have several inlet channels on a membrane, 
forming multiple junctions in between to increase the flow  rate, and have a pre-filter to 
avoid fouling of contaminant.  The AAO membrane filter device for bacteria viability 
detection may be the first one to be applied to POC tests, since it is established on 
several commercialized products and in vitro clinical tests have been conducted. In brief, 
a complete optimization for these membrane-based devices discussed in this dissertation 
should make them more suitable for real POC applications, contributing the 
development of rapid, accurate, reliable, and early diagnosis of patients.   
 72
REFERENCES 
 
1. A. J. Tüdős, G. A. J. Besselink and R. B. M. Schasfoort, Lab Chip, 2001, 1, 83. 
2. K. Lewandrowski, Clin. Lab. Med., 2009, 29, 421.  
3. S. L. Gutierres and T. E. Welty, Ann. Pharmacother., 2004, 38, 119. 
4. S. C. Terry, J. H. Jerman and J. B. Angell, Ieee T. Electron. Dev., 1979, 26, 1880. 
5. Agilent Technologies Inc., USA (www.agilent.com). 
6. R. Suriano, A. Kuznetsov, S. M. Eaton, R. Kiyan, G. Cerullo, R. Osellame, B. N. 
Chichkov, M. Levi and S. Turri, Appl. Surf. Sci., 2011, 257, 6243.  
7. X. Zhao and Y. C. Shin, Appl. Phys. A, 2011, 104, 713. 
8. M. Abonnenc, A.-L. Gassner, J. Morandini, J. Josserand and H. H. Girault, Anal. 
Bioanal. Chem., 2009, 395, 747.  
9. A. Stojanovic, G. R. J. Artus and S. Seeger, Nano Res., 2010, 3, 889. 
10. P. S. Nunes, P. D. Ohlsson, O. Ordeig and J. P. Kutter, Microfluid. Nanofluid., 2010, 
9, 145.  
11. M. J. Mescher, E. E. Leary Swan, J. Fiering, M. E. Holmboe, W. F. Sewell, S. G. 
Kujawa, M. J. McKenna and J. T. Borenstein, J. Microelectromech. S., 2009, 18, 501. 
12. M. E. Wilson, N. Kota, Y. Kim, Y. Wang, D. B. Stolz, P R. LeDuc and O. B. 
Ozdoganlar, Lab Chip, 2011, 11, 1550.  
13. J. C. McDonald, D. C. Duffy, J. R. Anderson, D. T. Chiu, H. Wu, O. J. Schueller and 
G. M. Whitesides, Electrophoresis, 2000, 21, 27. 
 73
14. J. M. Sidorova, N. Li, D. C. Schwartz, A. Folch and R. J. Monnat, Nat. Protoc., 2009, 
4, 849. 
15. A. O. Ogunniyi, C. M. Story, E. Papa, E. Guillen and J. C. Love, Nat. Protoc., 2009, 
4, 767. 
16. A. L. Paguirigan and D. J. Beebe, Nat. Protoc., 2007, 2, 1782. 
17. W. Browne, M. J. Rust, W. Jung, S. H. Lee and C. H. Ahn, Lab Chip, 2009, 9, 2941.
  
18. S.-H. Yoon, N.-G. Cha, J. S. Lee, J.-G. Park, D. J. Carter, J. L. Mead and C. M.F. 
Barry, Polym. Eng. Sci., 2010, 50, 411. 
19. A. Griffiths, S. Bigot, E. Brousseau, M. Worgull, M. Heckele, J. Nestler and J. 
Auerswald, Int. J. Adv. Manuf. Tech., 2010, 47, 111. 
20. U. M. Attia, S. Marson and J. R. Alcock, Microfluid. Nanofluid., 2009, 7, 1. 
21. A. Mathur, S.S. Roy, M. Tweedie, S. Mukhopadhyay, S. K. Mitra and J. A. 
McLaughlin, Curr. Appl. Phys., 2009, 9, 1199. 
22. L. P. Yeo, S. H. Ng, Z. F. Wang, H. M. Xia, Z. P. Wang, V. S0 Thang, Z. W0 Zhong 
and N. F. de Rooij, J. Micromech. Microeng., 2010, 20, 015017. 
23. E. W. K. Young, E. Berthier, D. J. Guckenberger, E. Sackmann, C. Lamers, I. 
Meyvantsson, A. Huttenlocher and D. J. Beebe, Anal. Chem., 2011, 83, 1408. 
24. S. Giselbrecht, T. Gietzelt, E. Gottwald, C. Trautmann, R. Truckenmüller, K. F. 
Weibezahn and A. Welle, Biomed. Microdevices, 2006, 8, 191. 
25. E. Roy, M. Geissler, J.-C. Galas and T. Veres, Microfluid. Nanofluid., 2011, 11, 235. 
 74
26. R. Truckenmüller, S. Giselbrecht, N. Rivron, E. Gottwald, V. Saile, A. van den Berg, 
M. Wessling and C. van Blitterswijk, Adv. Mater., 2011, 23, 1311. 
27. E. Roy, J.-C. Galas and T. Veres, Lab Chip, 2011, 11, 3193. 
28. D. Mark, S. Haeberle, G. Roth, F. von Stetten and R. Zengerle, Chem. Soc. Rev., 
2010, 39, 1153. 
29. M. Wang, N. Jing, I.-H. Chou, G. L. Cote and J. Kameoka, Lab Chip, 2007, 7, 630. 
30. G. A. Posthuma-Trumpie, J. Korf and A. van Amerongen, Anal. Bioanal. Chem., 
2009, 393, 569. 
31. R. Krska and A. Molinelli, Anal. Bioanal. Chem., 2009, 393, 67. 
32. H. L. Xie, W. Ma, L. Q. Liu, W. Chen, C. F. Peng, C. L. Xu and L. B. Wang, Anal. 
Chim. Acta, 2009, 634, 129. 
33. M. A. Unger, H. P. Chou, T. Thorsen, A. Scherer and S. R. Quake, Science, 2000, 
288, 113. 
34. T. Thorsen, S. J. Maerkl and S. R. Quake, Science, 2002, 298, 580. 
35. S. Haeberle and R. Zengerle, Lab Chip, 2007, 7, 1094. 
36. S. R. Quake and A. Scherer, Science, 2000, 290, 1536. 
37. N. G. Anderson, Science, 1969, 166, 317. 
38. M. Madou, J. Zoval, G. Y. Jia, H. Kido, J. Kim and N. Kim, Annu. Rev. Biomed. 
Eng., 2006, 8, 601. 
39. D. D. Nolte, Rev. Sci. Instrum., 2009, 80, 101101. 
40. B. S. Lee, J. N. Lee, J. M. Park, J. G. Lee, S. Kim, Y. K. Cho and C. Ko, Lab Chip, 
2009, 9, 1548. 
 75
41. Y. K. Cho, J. G. Lee, J. M. Park, B. S. Lee, Y. Lee and C. Ko, Lab Chip, 2007, 7, 
565. 
42. C.-K. Chou, N. Jing, H. Yamaguchi, P.-H. Tsou, H.-H. Lee, C.-T. Chen, Y.-N. Wang, 
S. Hong, C. Su, J. Kameoka and M.-C. Hung, Lab Chip, 2010, 10, 1793. 
43. C.-K. Chou, N. Jing, H. Yamaguchi, P.-H. Tsou, H.-H. Lee, C.-T. Chen, Y.-N. Wang, 
S. Hong, C. Su, J. Kameoka and M.-C. Hung, Analyst, 2010, 135, 2907. 
44. J. Lee, H. Moon, J. Fowler, T. Schoellhammer and C. J. Kim, Sens. Actuators, A, 
2002, 95, 259. 
45. M. G. Pollack, R. B. Fair and A. D. Shenderov, Appl. Phys. Lett., 2000, 77, 1725. 
46. A. Wixforth, Superlattice. Microstruct., 2003, 33, 389. 
47. A. Wixforth, C. Strobl, C. Gauer, A. Toegl, J. Scriba and Z. von Guttenberg, Anal. 
Bioanal. Chem., 2004, 379, 982. 
48. D. Beyssen, L. Le Brizoual, O. Elmazria and P. Alnot, Sens. Actuators, B, 2006, 118, 
380. 
49. Z. Guttenberg, H. Muller, H. Habermuller, A. Geisbauer, J. Pipper, J. Felbel, M. 
Kielpinski, J. Scriba and A. Wixforth, Lab Chip, 2005, 5, 308. 
50. M. V. Kakade, S. Givens, K. Gardner, K. H. Lee, D. B. Chase and J. F. Rabolt, J. Am. 
Chem. Soc., 2007, 129, 2777-2782. 
51. J. P. Chen, G. Y. Chang and J. K. Chen, Colloid. Surface. A, 2006, 313, 183-188. 
52. R. R. Klossner, H. A. Queen, A. J. Coughlin and W. E. Krause, Biomacromolecules, 
2008, 9, 2947-2953. 
53. Y. Wang and Y. L. Hsieh, J. Membr. Sci., 2008, 309, 73-81. 
 76
54. D. Yang, Y. Jin, Y. Zhou, G. Ma, X. Chen, F. Lu and J. Nie, Macromol. Biosci., 
2008, 8, 239-246.  
55. M. S. Peresin, Y. Habibi, J. O. Zoppe, J. J. Pawlak and O. J. Rojas, 
Biomacromolecules, 2010, 11, 674-681. 
56. J. J.Stankus, L. Soletti, K. Fujimoto, Y. Hong, D. A. Vorp and W. R. Wagner, 
Biomaterials, 2007, 28, 2738-2746. 
57. E.-R. Kenawy, F. I. Abdel-Hay, M. H. El-Newehy and G. E. Wnek, Mater. Chem. 
Phys., 2009, 113, 296-302. 
58. C. Yao, X. Li, K. G. Neoh, Z. Shi and E. T. Kang, J. Membrane. Sci., 2008, 320, 
259-267. 
59. T. Uyar, I. Cianga, L. Cianga, F. Besenbacher and Y. Yagci, Mater. Lett., 2009, 63, 
1638-1641. 
60. S. I. Jeong, I. D. Jun, M. J. Choi, Y. C. Nho, Y. M. Lee and H. Shin, Macromol. 
Biosci., 2008, 8, 627-637. 
61. N. J. Pinto, I. Ramos, R. Rojas, P.-C. Wang and A. T. Johnson, Sensor. Actuat. B-
Chem., 2008, 129, 621-627. 
62. D. H. Reneker and A. L. Yarin, Polymer, 2008, 49, 2387-2425. 
63. N. Bhardwaj and S. C. Kundu, Biotechnol. Adv., 2010, 28, 325-347. 
64. S. Sahoo, S. L. Toh and J. C. H. Goh, Biomaterials, 2010, 31, 2990-2998.  
65. Y. Dzenis, Science, 2004, 304, 1917-1919. 
66. X. Wang, C. Drew, S. H. Lee, K. J. Senecal, J. Kumar and L. A. Samuelson, Nano 
Lett., 2002, 2, 1273-1275. 
 77
67. H. Yoshimotoa, Y. M. Shina, H. Teraia and J. P. Vacantia, Biomaterials, 2003, 24, 
2077-2082. 
68. Y. Zhou, M. Freitag,J. Hone, C. Staii and A. T. Johnson, Jr., Appl. Phys. Lett., 2003, 
83, 3800-3802. 
69. T. J. Sill and H. A. von Recum, Biomaterials, 2008, 29, 1989-2006. 
70. S. Agarwal, J. H. Wendorff and A. Greiner, Polymer, 2008, 49, 5603-5621. 
71. V. Thavasi, G. Singh and S. Ramakrishna, Energ. Environ. Sci., 2008, 1, 205-221. 
72. S. Barth, F. Hernandez-Ramirez, J. D. Holmes and A. Romano-Rodriguez, Prog. 
Mater. Sci., 2010, 55, 563-627.  
73. M. J. Duffy, Clin. Chem., 2006, 52, 345-351. 
74. M. H. Kollef, Respir. Care., 2005, 50, 714. 
75. M. H. Kollef, L. E. Morrow, M. S. Niederman, K. V. Leeper, A. Anzueto, L. Benz-
Scott and F. J. Rodino, Chest, 2006, 129, 1210. 
76. M. H. Kollef and S. Ward, Chest, 1998, 113, 412. 
77. P. J. Z. Teixeira, R. Seligman, F. T. Hertz, D. B. Cruz and J. M. G. Fachel, J. Hosp. 
Infect., 2007, 65, 361. 
78. A. W. Bauer, W. M. Kirby, J. C. Sherris and M. Turck, Am. J. Clin. Pathol., 1966, 
45, 493.  
79. H. F. Charnbers, Clin. Microbiol. Rev., 1997, 10, 781. 
80. M. B. Huang, C. N. Baker, S. Banerjee and F. C. Tenover, J Clin Microbiol., 1992, 
30, 3243. 
81. L. K. McDougal, C. Thornsberry, J. Clin. Microbiol., 1986, 23, 832. 
 78
82. C. Thornsberry and L. K. McDougal, J. Clin. Microbiol., 1983, 18, 1084. 
83. S. Unal, K. Werner, P. DeGirolami, F. Barsanti and G. Eliopoulos, Antimicrob. 
Agents Chemother., 1994, 38, 345. 
84. G. L. Woods, G. S. Hall, I. Rutherford, K. J. Pratt and C. C. Knapp, J. Clin. 
Microbiol., 1986, 24, 349–352. 
85. M. K. York, L. Gibbs, F. Chehab and G. F. Brooks, J. Clin. Microbiol., 1996, 34, 
249. 
86. M. H. Kollef and S. Ward, Chest, 1998, 113, 412. 
87. R. H. Perry and D. H. Green, Perry’s Chemical Engineers’ Handbook, 7th edition, 
McGraw-Hill, 1997, 22-40. 
88. http://http://en.wikipedia.org/wiki/Synthetic_membrane 
89. http://www.whatman.com/products.aspx?PID=193 
90. H. Masuda, K. Yada and A. Osaka, Jpn. J. Appl. Phys., 1998, 37, L1340-L1342. 
91. P. Forrer, F. Schlottig, H. Siegenthaler and M. Textor, J. Appl. Electrochem., 2000, 
30, 533-541. 
92. A. P. Goodey, S. M. Eichfeld, K. K. Lew, J. M. Redwing and T. E. Mallouk, J. Am. 
Chem. Soc., 2007, 129, 12344-12345. 
93. J. K. Lee, W. K. Koh, W. S. Chae and Y. R. Kim, Chem. Commun., 2002, 2, 138-
139. 
94. J. Oh, Y. Tak and Y. Lee, Electrochem. Solid-State Lett., 2004, 7, C27-C30. 
95. J. G. Wang, M. L. Tian, N. Kumar and T. E. Mallouk, Nano Lett., 2005, 5, 1247-
1253. 
 79
96. S. Zhao, H. Roberge, A. Yelon and T. Veres, J. Am. Chem. Soc., 2006, 128, 12352-
12353. 
97. F. Qu, M. Yang, G. Shen and R. Yu, Biosens. Bioelectron., 2007, 22, 1749-1755.  
98. D. Li, R. S. Thompson, G. Bergmann and J. G. Lu, Adv. Mater., 2008, 20, 4575-
4578. 
99. M. D. Dickey, E. A. Weiss, E. J. Smythe, R. C. Chiechi, F. Capasso and G. M. 
Whitesides, ACS Nano, 2008, 2, 800-808. 
100. X. Gao, L. Liu, B. Birajdar, M. Ziese, W. Lee, M. Alexe and D. Hesse, Adv. Funct. 
Mater., 2009, 19, 3450-3455.  
101. V. Haehnel, S. Fahler, P. Schaaf, M. Miglierini, C. Mickel, L. Schultz and H. 
Schlorb, Acta Mater., 2010, 58, 2330-2337.   
102. H. C. Hesse, D. Lembke, L. Dossel, X. Feng, K. Mullen and L. Schmidt-Mende, 
Nanotechnology, 2011, 22, 055303. 
103. P. Ciambelli, L. Arurault, M. Sarno, S. Fontorbes, C. Leone, L. Datas, D. Sannino, 
P. Lenormand and S. L. Du Plouy, Nanotechnology, 22, 265613.  
104. J.-M. Moon, D. Akin, Y. Xuan, P. D. Ye, P. Guo and R. Bashir, Biomed. 
Microdevices., 2009, 11, 135–142. 
105. H. U. Osmanbeyoglu, T. B. Hur and H. K. Kim, J. Membr. Sci., 2009, 343,1–6. 
106. D. C. Kim, A.-R. Jang, D. J. Kang, Curr. Appl. Phys., 2009, 9, 1454-1458. 
107. M. Fleischmann, P. J. Hendra and A. J. McQuillan, Chem. Phys. Lett., 1974, 26, 
163-166. 
108. P. Mandal and S. A. Ramakrishna, Opt. Lett., 2011, 36, 3705. 
 80
109. N. Mattiucci, G. D'Aguanno, H. O. Everitt, J. V. Foreman, J. M. Callahan, M. C. 
Buncick and M. J. Bloemer, Opt. Express, 2012, 20, 1868. 
110. S. M. Mahurin, J. John, M. J. Sepaniak and S. Dai, Appl. Spectrosc., 2011, 65, 417. 
111. E. del Puerto, C. Domingo, S. Sanchez-Cortes, J. V. Garcia-Ramos and R. F. 
Aroca, J. Phys. Chem. C, 2011, 115, 16838. 
112. T. Y. Liao, B.-Y. Lee, C.-W. Lee and P.-K. Wei, Sens. Actuators. B, 2011, 156, 
245. 
113. L. Wu, H. C. Li, H. F. Zhao, Y. Sun, H. R. Xu, M. Lu, C. H. Yang, W. Z. Li and Z. 
Q. Li, Chinese. J. Anal. Chem., 2011, 39, 1159. 
114. E. Kammer, T. Dorfer, A. Csaki, E. Schumacher, P. A. Da Costa, N. Tarcea, W. 
Fritzsche, P. Rosch, M. Schmitt and J. Popp, J. Phys. Chem. C, 2012, 116, 6083. 
115. X. Dong, H. M. Gu and F. F. Liu, Spectrochim. Acta. Part A, 2012, 88, 97.  
116. S. Lee, J. H. Wong and S. J. Liu, Appl. Spectrosc., 2011, 65, 996.  
117. H. Wang, C. S. Levin. and N. J. Halas, J. Am. Chem. Soc., 2005, 127, 14992. 
118. S. K. Jha, Z. Ahmed, M. Agio, Y. Ekinci and J. F. Loffler, J. Am. Chem. Soc., 2012, 
134, 1966. 
119. N. Félidj, J. Aubard, G. Lévi, J. R. Krenn, M. Salerno, G. Schider, B. Lamprecht, 
A. Leitner, and F. R. Aussenegg, Phys. Rev. B: Condens. Matter Mater. Phys., 2002, 
65, 075419-1.  
120. J. Theiss, P. Pavaskar, P. M. Echternach, R. E. Muller and S. B. Cronin, Nano Lett., 
2010, 10, 2749. 
 81
121. N. Félidj, J. Aubard, G. Lévi, J. R. Krenn, A. Hohenau, G. Schider, A. Leitner, and 
F. R. Aussenegg, Appl. Phys. Lett., 2003, 82, 3095.  
122. B. Yan, A. Thubagere, W. R. Premasiri, L. D. Ziegler, L. Dal Negro and B. M. 
Reinhard, ACS Nano, 2009, 3, 1190.  
123. J. L. Abell, J. M. Garren and Y. P. Zhao, Appl. Spectrosc., 2011, 65, 734.  
124. Y. J. Liu, Z. Y. Zhang, R. A. Dluhy and Y. P. Zhao, J. Raman Spectrosc., 2010, 41, 
1112.  
125. X. B. Du, H. Y. Chu, Y. W. Huang and Y. P. Zhao, Appl. Spectrosc., 2010, 64, 781.  
126. S. Shanmukh, L. Jones, J. Driskell, Y. Zhao, R. Dluhy and R. A. Tripp, Nano Lett., 
2006, 6, 2630.  
127. G. V. P. Kumar, N. Rangarajan, B. Sonia, P. Deepika, N. Rohman and C. Narayana, 
Bull. Mater. Sci., 2011, 34, 207.  
128. W. B. Li, Y. Y. Guo and P. Zhang, J. Phys. Chem. C, 2010, 114, 7263.  
129. J. B. Jackson, S. L. Westcott, L. R. Hirsch, J. L. West and N. J. Halas, Appl. Phys. 
Lett., 2003, 82, 257.  
130. C. E. Talley, J. B. Jackson, C. Oubre, N. K. Grady, C. W. Hollars, S. M. Lane, T. 
R. Huser, P. Nordlander and N. J. Halas, Nano Lett., 2005, 5, 1569. 
131. C. M. S. Izumi, M. G. Moffitt and A. G. Brolo, J. Phys. Chem. C, 2011, 115, 
19104.  
132. S. K. Yang, W. P. Cai, L. C. Kong and Y. Lei, Adv. Funct. Mater., 2010, 20, 2527.  
133. M. A. Ochsenkuhn, C. J. Campbell, Chem. Commun., 2010, 46, 2799. 
 82
134. S. W. Bishnoi, Y. J. Lin, M. Tibudan, Y. M. Huang, M. Nakaema, V. Swarup and 
T. A. Keiderling, Anal. Chem., 2011, 83, 4053.  
135. G. Q. Liu, Y. Li, G. T. Duan, J. J. Wang, C. H. Liang and W. P. Cai, ACS Appl. 
Mater. Interfaces, 2012, 4, 1. 
136. E. C. Le Ru and P. G. Etchegoin, in Principles of Surface-Enhanced Raman 
Spectroscopy, Elsevier, Oxford, 2009, pp. 1-28. 
137. K. Kneipp, Y. Wang, H. Kneipp, L. T. Perelman, I. Itzkan, R. R. Dasari and M. S. 
Feld, Phys. Rev. Lett., 1997, 78, 1667.  
138. Y. Xia and G. M. Whitesides, Angew. Chem., Int. Ed., 1998, 37, 550. 
139. S. R. Quake and A. Scherer, Science, 2000, 290, 1536. 
140. J. Krzaczkowska, J. Gierszewski and G. Slosarek, J. Solution Chem., 2004, 33, 395. 
141. J. W. Zhou, A. V. Ellis and N. H. Voelcker, Electrophoresis, 2010, 31, 2. 
142. M. Li and D. P. Kim, Lab Chip, 2011, 11, 1126. 
 
 
 83
VITA 
Name: Pei-Hsiang Tsou 
Address: Department of Electrical & Computer Engineering, Texas A&M 
University, College Station, TX 77843-3128 
  
Email Address: tsou3@tamu.edu 
 
Education: B.S., Electronics Engineering, National Chiao Tung University, 
Hsinchu, Taiwan, 2001 
- M.S., Electrical Engineering, Texas A&M University, 2006 
 
Publications: 
1. Pei-Hsiang Tsou, Chao-Kai Chou, Sandra M Saldana, Mien-Chie Hung and Jun 
Kameoka, “The fabrication and testing of electrospun silica nanofiber membranes 
for the detection of proteins” Nanotechnology, 2008, 19, 445714 doi: 
10.1088/0957-4484/19/44/445714. 
2. Pei-Hsiang Tsou, Harini Sreenivasappa, Sungmin Hong, Masayuki Yasuike, 
Hiroshi Miyamoto, Keiyo Nakano, Takeyuki Misawa, Jun Kameoka, "Rapid 
antibiotic efficacy screening with aluminum oxide nanoporous membrane filter-
chip and optical detection system" Biosensors and Bioelectronics, 2010, 
doi:10.1016/j.bios.2010.06.034. 
3. Chao-Kai Chou, Nan Jing, Hirohito Yamaguchi, Pei-Hsiang Tsou, Heng-Huan Lee, 
Chun-Te Chen, Ying-Nai Wang, Sungmin Hong, Chin Su, Jun Kameoka and 
Mien-Chie Hung, "High speed digital protein interaction analysis using 
microfluidic single molecule detection system" Lab on a Chip, 2010, 10, 1793–
1798 doi:10.1039/c002937h. 
4. Chao-Kai Chou, Nan Jing, Hirohito Yamaguchi, Pei-Hsiang Tsou, Heng-Huan Lee, 
Chun-Te Chen, Ying-Nai Wang, Sungmin Hong, Chin Su, Jun Kameoka and 
Mien-Chie Hung, "Rapid detection of two-protein interaction with a single 
fluorophore by using a microfluidic device" Analyst, 2010, 
doi:10.1039/C0AN00229A. 
